The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression

Código QR

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression

Katharina Dannehl,1 Winfried Rief,1 Markus J Schwarz,2 Annika Hennings,1 Sabine Riemer,1 Verena Selberdinger,3 Theresa Stapf,3 Frank Euteneuer11Division of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany; 2Institute for Laboratory Medicine, Ludwig-Maxi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/61ad742b67f048d5bd65a00451a51843
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
por: Fornaro M, et al.
Publicado: (2011)

The impact of the duration of an untreated episode on improvement of depression and somatic symptoms
por: Hung CI, et al.
Publicado: (2015)

Aggressive behavior, cognitive impairment, and depressive symptoms in elderly subjects
por: Margari F, et al.
Publicado: (2012)

Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis
por: Chou YH, et al.
Publicado: (2017)

Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J
por: Sumiyoshi T, et al.
Publicado: (2021)

Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode
por: Yoshizawa K, et al.
Publicado: (2021)

Association between toll-like receptor 4 expression and symptoms of major depressive disorder
por: Wu MK, et al.
Publicado: (2015)

Noradrenergic symptom cluster in depression
por: Montgomery S, et al.
Publicado: (2011)

Investigation of facial emotion recognition, alexithymia, and levels of anxiety and depression in patients with somatic symptoms and related disorders
por: Öztürk A, et al.
Publicado: (2016)

Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain
por: Liu CH, et al.
Publicado: (2019)

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
por: Haro JM, et al.
Publicado: (2019)

Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
por: Harada E, et al.
Publicado: (2016)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms
por: Park CM, et al.
Publicado: (2014)

Depressive symptoms and childhood sleep apnea syndrome
por: Carotenuto M, et al.
Publicado: (2012)

Kynurenine and depressive symptoms in a poststroke population
por: Bensimon K, et al.
Publicado: (2014)

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
por: Wang G, et al.
Publicado: (2019)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

Transcranial magnetic stimulation for the treatment of major depression
por: Janicak PG, et al.
Publicado: (2015)

Cytokines and depression in cancer patients and caregivers
por: Li M, et al.
Publicado: (2017)

Childhood adversities and laboratory pain perception
por: Pieritz K, et al.
Publicado: (2015)

The relationship between insomnia and depressive symptoms: genuine or artifact?
por: Fadia Isaac, et al.
Publicado: (2011)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider M, et al.
Publicado: (2017)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013)

The cortisol awakening response and major depression: examining the evidence
por: Dedovic K, et al.
Publicado: (2015)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis GA, et al.
Publicado: (2015)

Is placebo useful in the treatment of major depression in clinical practice?
por: Marchesi C, et al.
Publicado: (2013)

Psychomotor retardation and externally oriented thinking in major depression
por: Luca M, et al.
Publicado: (2013)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Marty Hinz, et al.
Publicado: (2010)

Associations of serum cystatin C with depressive symptoms and suicidal ideation in major depressive disorder
por: Ting Sun, et al.
Publicado: (2021)

Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study
por: Wang G, et al.
Publicado: (2020)

Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study
por: Jinnin R, et al.
Publicado: (2016)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017)

Major depressive disorder: mechanism-based prescribing for personalized medicine
por: Saltiel PF, et al.
Publicado: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang X, et al.
Publicado: (2015)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak J, et al.
Publicado: (2013)

A meta-analysis of lipid peroxidation markers in major depression
por: Mazereeuw G, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang XF, et al.
Publicado: (2015)